Table 3.
Characteristics | Patient #1 | Patient #2 | Patient #3 | Patient #4 | Patient #5 |
---|---|---|---|---|---|
Intraprocedural outcomes | |||||
Prosthetic size, mm | 29 | 26 | 26 | 29 | 29 |
Procedure duration, min | 215 | 205 | 160 | 85 | 170 |
Fluoroscopy time, min | 35 | 26 | 19 | 13 | 22 |
Contrast volume, min | 142 | 133 | 114 | 89 | 118 |
Complications | |||||
Conversion to surgery | No | No | No | No | No |
Prosthesis displacement | No | No | No | No | No |
Annular rupture | No | No | No | No | No |
Paravalvular leakage | Trace | None | Trace | None | None |
Third-degree atrioventricular block | No | No | No | No | No |
Postprocedural transesophageal echocardiography parameters | |||||
Extracorporeal membrane oxygenation | No | No | Yes | No | No |
Left ventricular ejection fraction,% | 54 | 50 | 35 | 53 | 55 |
Mitral valve peak velocity, m/s | 1.4 | 1.6 | 1.2 | 1.7 | 1.1 |
Mean mitral valve pressure gradient, mmHg | 3 | 3 | 2 | 3 | 2 |
Mean left ventricular outflow tract pressure gradient, mmHg | 1 | 4 | 1 | 2 | 2 |